Abstract
Biochemical and genetic characterizations that support the conclusion that the variant BRCA2 IVS7 + 2T → G represents a deleterious mutation are presented. RNA analysis from a breast cancer patient with BRCA2 IVS7 + 2T → G showed that the productive message was produced from only one chromosome. A haplotype analysis confirmed that the intronic variant resides on the chromosome that does not produce the normal mRNA. Additionally, an RNA splicing product that deletes exon 7 was produced by the chromosome that carries BRCA2 IVS7 + 2T → G. The deletion of exon 7 from the RNA alters the open reading frame by removing residues 249–287 and incorporating 18 abnormal amino acids before terminating with an opal stop codon. The experimental approach presented produces strong evidence of the presence of a deleterious mutation, because the contribution by both chromosomes to each RNA species analyzed was tracked using a coding region polymorphism as a marker. Furthermore, a single nucleotide polymorphism (SNP) haplotype analysis that confirms the location of the intronic variant and an associated family history that shows a high incidence of cancer supported these biochemical data.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: August 7, 2000 / Accepted: September 18, 2000
Rights and permissions
This article is cited by
-
Bypass of premature stop codons and generation of functional BRCA2 by exon skipping
Journal of Human Genetics (2020)
-
Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption
Cell Death & Disease (2017)
-
Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes
Breast Cancer Research and Treatment (2012)
-
Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations
Familial Cancer (2010)
-
The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicing of the transcripts
Breast Cancer Research and Treatment (2009)